The purpose of this study is to evaluate the safety and immune response of an investigational, intranasal flu vaccine.
Duration: Approximately 7 months
Number of visits to AMR Lexington: 7
Qualifications: Participants must be non-smoking adults, ages18-49 years old, who are in general good health and who do not suffer from any chronic lung disease or disorders. Other criteria also apply.